We are international
Donate
publications TEXT SIZE   
myeloma today    back

Fall 2005 Volume 6, Issue 6:
Dear Reader
By Susie Novis
The IMF, along with researchers, physicians, patients, and industry leaders, is extremely excited as we prepare for the annual American Society of Hematology (ASH) meeting, this year being held in Atlanta, Georgia on December 10th through 13th. The I
12.08.05

The IMF, along with researchers, physicians, patients, and industry leaders, is extremely excited as we prepare for the annual American Society of Hematology (ASH) meeting, this year being held in Atlanta, Georgia on December 10th through 13th. The ASH meeting is the annual high point of the year in blood cancer research, and myeloma research is fast becoming the bellwether for blood-cancer studies and treatment. The IMF, through our groundbreaking program, Bank On A Cure®, is at the forefront of it all. This year, five abstracts from Bank On A Cure research have been accepted at ASH, an impressive accomplishment. The IMF will once again be on site at ASH conducting web interviews with leading myeloma clinicians and researchers, capturing their first impressions and responses to the new data being presented. These reports from ASH, bring you breaking news as it happens.

However, those of you familiar with the work of the IMF should not be surprised by this announcement. Over the years, the IMF has awarded a total of 65 grants by means of the Brian D. Novis Research Grant program, to clinical researchers around the world. These grants are producing amazing results in the area of myeloma treatment as well as our overall understanding of the disease. At the annual ASH meeting, the IMF announces the grant winners for the upcoming year. Please look to future editions of Myeloma Today and to our website www.myeloma.org, for information about our newest awardees.

In all aspects of cancer research, knowledge is power, and the more you know about developments in myeloma research, the better equipped you are to face this devastating disease. To that end, please use all of the tools that the IMF provides. If you do not already subscribe to this publication, please call us at 800-452-CURE (2873) and do so today! If you have internet access, please visit our award-winning website, and subscribe to our weekly e-mail newsletter, the Myeloma Minute. Our thorough catalogue of publications is overseen by our chairman, Dr. Brian G.M. Durie, and our materials have proven to be the most informative and helpful resources available. They can be viewed online or ordered directly through our website or by telephone. Lastly, all of those who have called our toll-free hotline and spoken with Debbie, Nancy, and Paul know that we are available to help you better understand myeloma research and treatment with the most up-to-date information possible. Please tell those who may not know about the IMF that we are available to assist anyone touched by this disease.

We are here to help you in any and all ways possible, and look forward to reporting back to you about our accomplishments and the important updates on the advances in myeloma research and treatment that will be presented at this year's ASH conference.

Best wishes.


 related articles